UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

 

For the Month of October, 2020

 

Commission File Number: 001-37353

 

BIONDVAX PHARMACEUTICALS LTD.

(Translation of registrant’s name into English)

Jerusalem BioPark, 2nd Floor

Hadassah Ein Kerem Campus

Jeusalem, Israel

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

 

 

 

 

Exhibit Index

Exhibit
No.
  Description
     
99.1   Unaudited Condensed Interim Financial Statements of the Company for the period ended June 30, 2020
99.2   Management’s Discussion and Analysis of Financial Condition
99.3   Description of Risk Factors
101.INS   XBRL Instance Document
101.SCH   XBRL Schema File
101.CAL   XBRL Calculation File
101.DEF   XBRL Definition File
101.LAB   XBRL Labels File
101.PRE   XBRL Presentation File

This Report on Form 6-K is hereby incorporated by reference into the Company’s Registration Statement on Form F-3 (Registration No. 333-240189) and its Registration Statement on Form S-8 (Registration No. 333-239344).

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BiondVax Pharmaceuticals Ltd.
     
Date: October 1, 2020 By: /s/ Ron Babecoff
    Ron Babecoff
    Chief Executive Officer

 

 

 

 

2

 

BiondVax Pharmaceuticals (NASDAQ:BVXV)
Historical Stock Chart
From Dec 2020 to Jan 2021 Click Here for more BiondVax Pharmaceuticals Charts.
BiondVax Pharmaceuticals (NASDAQ:BVXV)
Historical Stock Chart
From Jan 2020 to Jan 2021 Click Here for more BiondVax Pharmaceuticals Charts.